The CLO fight is over; the pricing fight is starting

When the NAIC's summer national meeting ran in Columbus from Aug. 11 to 14, the CLO risk-based capital fight that had absorbed years of actuarial study and industry comment did not top anyone's list afterward. Martha Leiper, who leads insurance advisory at Nuveen and followed the sessions remotely because of a scheduling conflict, wrote the recap, and her read is a change of subject: with the CLO factors settled, attention has turned to credit ratings, negative interest maintenance reserve, residential mortgage loans and corporate-owned life insurance.

This is one advisor's account of a four-day meeting, published as a summary that Nuveen's own disclosure says is not all-inclusive and may contain material omissions, and the firm states it has no affiliation with the NAIC and produced the note without the regulator's involvement. And the ground that moved is subject matter, not volume — by Leiper's account the regulatory agenda remains just as full as before; nothing in the note says the NAIC has finished with capital.

That distinction matters because the two categories of agenda item are not the same kind of negotiation: a CLO factor is finite, one asset class, one table, a defined set of holders to consult, and a result that can be modeled once it prints. Credit ratings travel through the designation machinery that sets the charge on the bond portfolio, which means an item on ratings reaches across the general account rather than into one sleeve of it. The rating committee prices private credit before regulators, and that ordering is why a ratings item deserves more of an insurer's attention than another factor grid.

Negative interest maintenance reserve is the easiest item to skim and the closest to the capital line. The reserve is where realized gains and losses on fixed-income sales sit before they amortize into income, which puts a negative balance in surplus territory, several steps removed from the yield conversation investment committees usually have. Its arrival on the agenda suggests balances large enough for the working groups to take up, and insurers are carrying a strong underwriting half into a rate reversal that changes what the reinvestment book throws off, so the treatment of the reserve's sign lands at an awkward moment.

Residential mortgage loans and corporate-owned life insurance reached the agenda as emerging questions, and the recap does not say what form the questions take — designation, valuation, or the factors themselves. Both are general-account assets whose treatment runs through the same channels as everything else on the agenda, so questions about them are questions about what the balance sheet holds, not only about how a single instrument behaves — a broader posture than the CLO years, when the argument was bounded by the size of the CLO book.

The CLO chapter is also a lesson in the shape of this regulator's capital work: years of actuarial study and industry feedback produced an outcome the industry has settled into, and Leiper's framing carries the sound of a cost absorbed. A long runway, heavy comment and an end state nobody loves is the customary sequence, but what has changed is the clock — private-credit and offshore-reinsurance work sits on a short comment window, and the charge drafted in that window will price general-account yield trades long after the deals that prompted it have closed. CLO factors could take a decade because they touched one sleeve; the replacement list does not have that luxury, because its items surface in every quarter's statutory filing rather than in one portfolio's factor table.

Read alongside the rest of this year's capital work, the Columbus list points the same way: statutory reporting and capital treatment for illiquid assets and offshore reinsurance are already on a comment clock, jurisdiction risk is moving from a checklist into the capital formula, and credit ratings are back in view. Leiper's note adds two items that had not appeared in that sequence — a reserve whose sign moves surplus, and questions about loan and COLI holdings — which suggests a perimeter still widening rather than one being closed out.

The practical consequence for anyone running a general account is that the inputs they can price are narrowing while the unsettled ones multiply: CLO factors, once the loudest source of uncertainty on the asset side, are now the known quantity, while the charge that decides what a private-credit allocation costs in capital and the designations that decide what a bond costs are not. An insurer that budgeted regulatory attention for the CLO table and none for the ratings work has the allocation backwards.

Nuveen's commercial position is worth naming: the firm manages money for insurers, which makes its read of the meeting a stakeholder's read. The direction of travel is still worth taking seriously, but the operative items should be checked against what the working groups actually adopt.

The CLO factor table is now the piece of general-account capital policy an insurer can model with confidence; everything that replaced it on the agenda is open, and the next round of working-group agendas will show whether credit ratings becomes a drafting charge or stays a conversation.